$0.00
0.00%
Nasdaq, Thu, Jul 03 2025
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Molecular Templates, Inc. Stock price

$0.00
+0.00 0.00% 1M
-0.03 99.67% 6M
-0.04 99.75% YTD
-1.19 99.99% 1Y
-13.02 100.00% 3Y
-202.65 100.00% 5Y
-653.40 100.00% 10Y
-8,167.50 100.00% 20Y
Nasdaq, Closing price Thu, Jul 03 2025
+0.00 0.00%
ISIN
US6085501095
Symbol
MTEM
Sector
Industry

Key metrics

Basic
Market capitalization
$0.0
Enterprise Value
$-9.7m
Net debt
positive
Cash
$9.7m
Shares outstanding
6.6m
Valuation (TTM | estimate)
P/E
0.0 | negative
P/S
0.0 | 0.4
EV/Sales
negative | 0.5
EV/FCF
0.4
P/B
0.0
Financial Health
Equity Ratio
11.9%
Return on Equity
-192.9%
ROCE
-99.1%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$25.5m | $12.3m
EBITDA
$-14.0m | -
EBIT
$-18.9m | -
Net Income
$-15.6m | $-19.3m
Free Cash Flow
$-23.9m
Growth (TTM | estimate)
Revenue
-49.4% | -78.5%
EBITDA
62.3% | -
EBIT
57.8%
Net Income
66.6% | -137.4%
Free Cash Flow
67.4%
Margin (TTM | estimate)
Gross
-
EBITDA
-54.9% | -
EBIT
-74.0%
Net
-61.3% | -156.3%
Free Cash Flow
-93.9%
More
EPS
$-2.4
FCF per Share
$-3.6
Short interest
6.5%
Employees
62
Rev per Employee
$920.0k
Show more

Is Molecular Templates, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,966 stocks worldwide.

Molecular Templates, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Molecular Templates, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Molecular Templates, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Molecular Templates, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
25 25
49% 49%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 15 15
34% 34%
59%
- Research and Development Expense 29 29
59% 59%
115%
-14 -14
62% 62%
-55%
- Depreciation and Amortization 4.87 4.87
36% 36%
19%
EBIT (Operating Income) EBIT -19 -19
58% 58%
-74%
Net Profit -16 -16
67% 67%
-61%

In millions USD.

Don't miss a Thing! We will send you all news about Molecular Templates, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.

Head office United States
CEO Craig Jalbert
Employees 62
Founded 2000
Website www.mtem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today